Decision Resources, one of the world’s leading research and advisory firms for pharmaceutical and healthcare issues, finds that, although the Methicillin-resistant (MRSA) drugmarket is currently ...

Developers working on methicillin-resistant staphylococcus aureus (MRSA) treatments market are expected to invest resources into research and development activities, for the generation of new product ...

According to the Centers for Disease Control and Prevention (CDC), between 2019 and 2023, there was a 460% increase in drug-resistant bacteria.

MRSA (methicillin-resistant Staphylococcus aureus) is a well known superbug, a pathogenic microbe that can cause serious or fatal infections, which are resistant to treatment with standard antibiotics ...